These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19475464)

  • 1. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.
    Geloneze B; Geloneze SR; Fiori C; Stabe C; Tambascia MA; Chaim EA; Astiarraga BD; Pareja JC
    Obes Surg; 2009 Aug; 19(8):1077-83. PubMed ID: 19475464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.
    Rubino F; Marescaux J
    Ann Surg; 2004 Jan; 239(1):1-11. PubMed ID: 14685093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.
    Cohen R; Caravatto PP; Correa JL; Noujaim P; Petry TZ; Salles JE; Schiavon CA
    Surg Obes Relat Dis; 2012; 8(4):375-80. PubMed ID: 22410638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.
    Klein S; Fabbrini E; Patterson BW; Polonsky KS; Schiavon CA; Correa JL; Salles JE; Wajchenberg BL; Cohen R
    Obesity (Silver Spring); 2012 Jun; 20(6):1266-72. PubMed ID: 22262157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.
    Geloneze B; Geloneze SR; Chaim E; Hirsch FF; Felici AC; Lambert G; Tambascia MA; Pareja JC
    Ann Surg; 2012 Jul; 256(1):72-8. PubMed ID: 22664560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.
    Cohen R; le Roux CW; Papamargaritis D; Salles JE; Petry T; Correa JL; Pournaras DJ; Galvao Neto M; Martins B; Sakai P; Schiavon CA; Sorli C
    Diabet Med; 2013 Dec; 30(12):1482-6. PubMed ID: 23802863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index<24 kg/m2.
    Jiang F; Zhu H; Zheng X; Tu J; Zhang W; Xie X
    Surg Obes Relat Dis; 2014; 10(4):641-6. PubMed ID: 24238729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients.
    Deutsch L; Ben Haim L; Sofer Y; Gluck N; Santo E; Fishman S
    Surg Obes Relat Dis; 2018 Oct; 14(10):1561-1569. PubMed ID: 30449512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].
    Wang Y; Zhang ZZ; Wang L; Deng ZZ; Jiao YB; Zou ZD
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2858-61. PubMed ID: 20137669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compared to Sleeve Gastrectomy, Duodenal-Jejunal Bypass with Sleeve Gastrectomy Gives Better Glycemic Control in T2DM Patients, with a Lower β-Cell Response and Similar Appetite Sensations: Mixed-Meal Study.
    Zachariah PJ; Chen CY; Lee WJ; Chen SC; Ser KH; Chen JC; Lee YC
    Obes Surg; 2016 Dec; 26(12):2862-2872. PubMed ID: 27138599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus.
    Weng SG; Zhang B; Wang X; Chen H
    Obes Surg; 2017 Aug; 27(8):2067-2072. PubMed ID: 28233263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.
    Frenken M; Cho EY
    Obes Facts; 2011; 4 Suppl 1(Suppl 1):13-7. PubMed ID: 22027284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes.
    Cohen RV; Neto MG; Correa JL; Sakai P; Martins B; Schiavon CA; Petry T; Salles JE; Mamedio C; Sorli C
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E279-82. PubMed ID: 23337729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
    de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
    Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
    Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
    Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal-Jejunal Exclusion Surgery Improves Type 2 Diabetes in a Rat Model Through Regulation of Early Glucose Metabolism.
    Guan W; Cui Y; Bu H; Liu J; Zhao S; Zhao Q; Ma X
    Can J Diabetes; 2020 Jul; 44(5):401-406.e1. PubMed ID: 32279935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.
    Glaysher MA; Mohanaruban A; Prechtl CG; Goldstone AP; Miras AD; Lord J; Chhina N; Falaschetti E; Johnson NA; Al-Najim W; Smith C; Li JV; Patel M; Ahmed AR; Moore M; Poulter N; Bloom S; Darzi A; Le Roux C; Byrne JP; Teare JP
    BMJ Open; 2017 Nov; 7(11):e018598. PubMed ID: 29146657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Gastrogastric Fistula Closure in Type 2 Diabetes.
    Meister KM; Schauer PR; Brethauer SA; Aminian A
    Obes Surg; 2018 Apr; 28(4):1086-1090. PubMed ID: 29090378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.